Cargando…
Introduction of new oral antiplatelet drugs in myocardial infarction hospital network: initial experience
Autores principales: | Rakowski, Tomasz, Dziewierz, Artur, Siudak, Zbigniew, Kleczyński, Paweł, Dubiel, Jacek S., Dudek, Dariusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971439/ https://www.ncbi.nlm.nih.gov/pubmed/23624705 http://dx.doi.org/10.1007/s11239-013-0930-z |
Ejemplares similares
-
Early administration of abciximab reduces mortality in female patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the EUROTRANSFER Registry)
por: Dziewierz, Artur, et al.
Publicado: (2012) -
Impact of smoking status on outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
por: Rakowski, Tomasz, et al.
Publicado: (2012) -
Age-related differences in treatment strategies and clinical outcomes in unselected cohort of patients with ST-segment elevation myocardial infarction transferred for primary angioplasty
por: Dziewierz, Artur, et al.
Publicado: (2012) -
Predictive Utility of NT-pro BNP for Infarct Size and Left Ventricle Function after Acute Myocardial Infarction in Long-Term Follow-Up
por: Kleczyński, Paweł, et al.
Publicado: (2013) -
Impact of intra-aortic balloon pump on long-term mortality of unselected patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock
por: Dziewierz, Artur, et al.
Publicado: (2014)